Commonwealth Fund January 4, 2024
Evan D. Gumas, Paige Huffman, Irene Papanicolas, Reginald D. Williams II

TOPLINES

Prices for 10 drugs commonly prescribed for millions of older Americans are, on average, three times higher than prices in other high-income countries

Even after price rebates and discounts, Americans pay significantly more for brand-name drugs than people in most other countries — leaving room for further reductions in upcoming Medicare drug price negotiations

Americans pay more for brand-name prescription medications than do residents of most other countries, with per capita spending on pharmaceuticals nearly three times the average of other member nations of the Organisation for Economic Co-operation and Development (OECD).1 In 2022, high costs forced one of five U.S. adults age 65 and older to skip or delay filling a prescription, miss or reduce doses, or use...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech, Provider
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways

Share This Article